Sussex Man Doing Well A Year And A Half After New Brain Cancer Treatment

Apr 19

Written By Glioblastoma Research

Glioblastoma Research

FDA Approves Ojemda For Children With Relapsed Or Refractory Brain Tumors

Integrating Physiotherapy For Enhancing Functional Recovery In Glioblastoma